Webinar | June 13, 2024

Enabling Complexity: Drug Substance Manufacturing Via Continuous Flow

Source: Cambrex

Continuous flow technology has become a cornerstone of modern pharmaceutical manufacturing. As drug substance molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology. This webinar explores how flow chemistry facilitates the integration of complex synthetic methods, previously confined to research laboratories, into clinical and commercial production of Active Pharmaceutical Ingredients (APIs).

Dr. Matthew Bio, Chief Scientific Officer at Cambrex, showcases the application of flow technology for scaling up modern synthetic approaches from pilot-scale to commercial production. Specific examples will delve into the development and implementation of flow processes for cryogenic organometallic reactions and photochemistry. Additionally, Dr. Bio discusses the value of data-rich experimentation in accelerating development timelines and achieving first-time-right manufacturing.

View the webinar below to explore the relevance of continuous flow technology in pharmaceutical manufacturing as well as use cases to support the utilization of continuous flow throughout drug development.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma